Tandem secures FDA approval for Control-IQ+ use in pregnancy

Tandem Diabetes Care has received approval from the US Food and Drug Administration (FDA) for its Control-IQ+ automated ...
BMJ Open Sport & Exercise Medicine

Effect of breaking up sitting with regular active breaks on glucose management and vascular function in adults with type 1 diabetes who use hybrid closed-loop insulin …

Sedentary behaviour is associated with an increased risk of cardiovascular disease and all-cause mortality in people with ...
The Lancet

Freedom through technology: transforming management of type 2 diabetes

Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...

Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System

The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a ...